Snowball logo
logo
3000

Inner Mongolia Furui Med Sci

300049 SHE
¥46.38+¥1.86  (4.18%)
Estimate
P/E
78.6
EPS
0.59
Beta
-0.408
Growth
Revenue, YoY
9%
Net income, YoY
11.03%
FCF, YoY
99.02%
Forecast
P/E (FWD)
34.1
EPS (FWD)
1.36
Dividends
Dividend yield
0.32%
Annual payout
¥0.15
Next ex. div date
July 6, 27
Payout
26.89%
Div.rating
About the company
Ticker
300049
ISIN
CNE100000KG1
Country
China
Sector (GICS)
Healthcare
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liver disease; and FibroView data management software. It provides digital health management services; compound turtle shell softening liver tablets; and prescription drugs. The company was formerly known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. Inner Mongolia Furui Medical Science Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.

Frequently asked questions

What sector does Inner Mongolia Furui Med Sci (300049) operate in?

Inner Mongolia Furui Med Sci belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Inner Mongolia Furui Med Sci (300049) current stock price?

As of the latest data, Inner Mongolia Furui Med Sci stock price is CN¥46.38, with a previous close of CN¥44.52. Inner Mongolia Furui Med Sci gained CN¥1.86 in the last trading session, representing a 4.18% increase.

What is Inner Mongolia Furui Med Sci (300049) current market capitalization?

Inner Mongolia Furui Med Sci market cap is approximately 12.24 billion.

What is Inner Mongolia Furui Med Sci (300049) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.59, and the forward EPS is CN¥1.36.

What is Inner Mongolia Furui Med Sci (300049) Price-to-Earnings (P/E) ratio?

Inner Mongolia Furui Med Sci current P/E ratio is 78.61, with a forward P/E of 34.1.

Does Inner Mongolia Furui Med Sci (300049) pay dividends?

Yes. Inner Mongolia Furui Med Sci pays annual dividends with an annualized yield of 0.32% and an estimated annual payout of CN¥0.15 per share.

When is the next ex-dividend date for Inner Mongolia Furui Med Sci (300049)?

The next ex-dividend date is scheduled for July 06, 2027.

What is Inner Mongolia Furui Med Sci (300049) beta (volatility) score?

Inner Mongolia Furui Med Sci has a beta of -0.408, indicating lower volatility than the overall market.